Clinical Trials Browser

Interventional × Carcinoma, Renal Cell × Lapatinib × Clear all

NCT00158782 2017-11-17

Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients

Phase 1 Completed

Carcinoma, Renal Cell

NCT00516672 2017-11-13

Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors

Phase 1 Completed

Carcinoma, Renal Cell, Neoplasms